Table II.
Differentially-expressed genes associated with functions and phenotypes.
| Gene symbol | Description | Log2FC | P-value | Gene ontology term |
|---|---|---|---|---|
| Upregulated | ||||
| Hbegf | Heparin binding EGF-like growth factor | −2.86 | 3.79×10−34 | Angiogenesis; extracellular space; epidermal growth factor receptor signaling pathway; growth factor activity |
| Ptgs2 | Prostaglandin-endoperoxide synthase 2 | −1.88 | 2.83×10−09 | Negative regulation of toll-like receptor signaling pathway; prostaglandin biosynthetic process; |
| Cxcl2 | C-X-C motif chemokine ligand 2 | −3.97 | 3.80×10−07 | Cytokine activity; extracellular region; inflammatory response; G-protein coupled receptor signaling pathway; neutrophil chemotaxis |
| Tgf-β1 | Transforming growth factor-β1 | −1.48 | 1.55×10−06 | Transcription coactivator activity; focal adhesion; positive regulation of epithelial to mesenchymal transition; Wnt signaling pathway |
| IL-1β | Interleukin-1β | −2.58 | 2.28×10−04 | Activation of MAPK activity; positive regulation of protein phosphorylation cytokine activity |
| Downregulated | ||||
| Ins2 | Insulin II | 5.01 | 7.42×10−11 | Negative regulation of transcription from RNA polymerase II promoter; MAPK cascade; negative regulation of acute inflammatory response; extracellular region |
| Tsc1 | Tuberous sclerosis 1 | 1.31 | 4.44×10−09 | Regulation of cell-matrix adhesion; adaptive immune response; protein binding; cytoplasm |
| Sgk2 | Serine/threonine kinase 2 | 1.22 | 1.06×10−08 | Nucleotide binding; regulation of cell growth; protein serine/threonine kinase activity; cytoplasm |
| Erbb3 | Erb-B2 receptor tyrosine kinase 3 | 1.07 | 3.75×10−07 | Nucleotide binding; protein kinase activity; transmembrane receptor protein tyrosine kinase activity; receptor signaling protein tyrosine kinase activity; protein binding |
| Adgrb1 | Adhesion G protein-coupled receptor B1 | 1.17 | 1.24×10−06 | Transmembrane signaling receptor activity; G-protein coupled receptor activity; protein binding; plasma membrane |
FC, fold change; MAPK, mitogen-activated protein kinase.